Genetic heterogeneity in ductal carcinoma of the breast

Laboratory Investigation

Volumn 80, Issue 3, 2000, Pages 291-301

  Lichy, Jack H ^a   Dalbègue, Fabienne ^a   Zavar, Maryam ^a   Washington, Constance ^a   Tsai, Mark M ^a   Sheng, Zong Mei ^a   Taubenberger, Jeffery K ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CONTROLLED STUDY; CYTOGENETICS; GENE SEQUENCE; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0343619372     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780034     Document Type: Article

References (55)

1. Aldaz CM, Chen T, Sahin A, Cunningham J, and Bondy M (1995). Comparative allelotype of in situ and invasive human breast cancer: High frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55:3976-3981.
2. Anbazhagan R, Fujii H, and Gabrielson E (1999). Microsatellite instability is uncommon in breast cancer. Clin Cancer Res 5:839-844.
3. Boland CR, Sato J, Appelman HD, Bresalier RS, and Feinberg AP (1995). Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1:902-909.
4. Brenner AJ and Aldaz CM (1997). The genetics of sporadic breast cancer. Prog Clin Biol Res 396:63-82.
5. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, and Vogelstein B (1998). Mutations of mitotic checkpoint genes in human cancers [See comments]. Nature 392:300-303.
6. Callahan R, Cropp CS, Merlo GR, Liscia DS, Cappa AP, and Lidereau R (1992). Somatic mutations and human breast cancer. A status report. Cancer 69:1582-1588.
7. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B, and Slamon DJ (1996). DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13:1971-1981.
8. Cheng L, Song SY, Pretlow TG, Abdul-Karim FW, Kung HJ, Dawson DV, Park WS, Moon YW, Tsai ML, Linehan WM, Emmert-Buck MR, Liotta LA, and Zhuang Z (1998). Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90:233-237.
9. Contegiacomo A, Palmirotta R, De Marchis L, Pizzi C, Mastranzo P, Delrio P, Petrella G, Figliolini M, Bianco AR, Frati L, Cama A, and Mariani-Costantini R (1995). Microsatellite instability and pathological aspects of breast cancer. Int J Cancer 64:264-268.
10. Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, and Smith HS (1994). Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54:499-505.
11. Deng G, Lu Y, Zlotnikov G, Thor AD, and Smith HS (1996). Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274:2057-2059.
12. Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes AM, Andersen JA, and Heim S (1995). Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 60:49-53.
13. Dillon EK, de Boer WB, Papadimitriou JM, and Turbett GR (1997). Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Cancer 76:156-162.
14. Eyfjord JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, and Anamthawat-Jonsson K (1995a). p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res 55:646-651.
15. Eyfjord JE, Thorlacius S, Valgardsdottir R, Gretarsdottir S, Steinarsdottir M, and Anamthawat-Jonsson K (1995b). TP53 abnormalities and genetic instability in breast cancer. Acta Oncol 34:663-667.
16. Fearon ER and Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell 61:759-767.
17. Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI, and Menard S (1999). Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations. J Pathol 187:424-427.
18. Fujii H, Marsh C, Cairns P, Sidransky D, and Gabrielson E (1996). Genetic divergence in the clonal evolution of breast cancer. Cancer Res 56:1493-1497.
19. Fujii S, Takeshima Y, Arihiro K, Kaneko M, and Inai K (1998). Microsatellite instability in breast cancers with special reference to patients' age and bilaterality. Hiroshima J Med Sci 47:89-97.
20. Gorgoulis VG, Koutroumbi EN, Kotsinas A, Zacharatos P, Markopoulos C, Giannikos L, Kyriakou V, Voulgaris Z, Gogas I, and Kittas C (1998). Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. Mol Med 4:807-822.
21. Heim S, Teixeira MR, Dietrich CU, and Pandis N (1997). Cytogenetic polyclonality in tumors of the breast. Cancer Genet Cytogenet 95:16-19.
22. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, and Hamelin R (1997). BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57:300-303.
23. Huiping C, Johannsdottir JT, Arason A, Olafsdottir GH, Eiriksdottir G, Egilsson V, and Ingvarsson S (1999). Replication error in human breast cancer: Comparison with clinical variables and family history of cancer. Oncol Rep 6:117-122.
24. Jonsson M, Johannsson O, and Borg A (1995). Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer. Eur J Cancer 31A:2330-A2334.
25. Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, and Page DL (1997). Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy. Am J Pathol 150:1925-1932.
26. Knudson AG (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-824.
27. Knudson AG, Jr (1985). Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443.
28. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, and Isola J (1997). Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597-1604.
29. Larson PS, de las Morenas A, Cupples LA, Huang K, and Rosenberg CL (1998). Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 152:1591-1598.
30. Lichy J, Zavar M, Tsai M, O'Leary T, and Taubenberger J (1998). Loss of heterozygosity at chromosome 11p15 during histological progression of ductal carcinoma of the breast. Am J Path.
31. Macintosh CA, Stower M, Reid N, and Maitland NJ (1998). Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 58:23-28.
32. Niederacher D, Schnurch HG, An HX, Ellenberger I, Dall P, van Roeyen CR, Kuppers V, and Beckmann MW (1996). Detection of sequential genetic alterations relevant for breast cancer development. Eur J Cancer Prev 5:497-503.
33. Nowell PC (1976). The clonal evolution of tumor cell populations. Science 194:23-28.
34. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, and Mitelman F (1993). Chromosome analysis of 20 breast carcinomas: cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosomes Cancer 6:51-57.
35. Paulson TG, Wright FA, Parker BA, Russack V, and Wahl GM (1996). Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56:4021-4026.
36. Petersson C, Pandis N, Mertens F, Adeyinka A, Ingvar C, Ringberg A, Idvall I, Bondeson L, Borg A, Olsson H, Kristoffersson U, and Mitelman F (1996). Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Genes Chromosomes Cancer 16: 185-188.
37. Petersson C, Pandis N, Rizou H, Mertens F, Dietrich CU, Adeyinka A, Idvall I, Bondeson L, Georgiou G, Ingvar C, Heim S, and Mitelman F (1997). Karyotypic abnormalities in fibro-adenomas of the breast. Int J Cancer 70:282-286.
38. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, and Travis WD (1996). Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 148:1531-1541.
39. Rosenberg CL, de las Morenas A, Huang K, Cupples LA, Faller DV, and Larson PS (1996). Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 98:1095-1100.
40. Rush EB, Calvano JE, van Zee KJ, Zelenetz AD, and Borgen PI (1997). Microsatellite instability in breast cancer. Ann Surg Oncol 4:310-315.
41. Shaw JA, Walsh T, Chappell SA, Carey N, Johnson K, and Walker RA (1996). Microsatellite instability in early sporadic breast cancer. Br J Cancer 73:1393-1397.
42. Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S, and Spandidos DA (1997). Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol 18:157-166.
43. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, and Bova GS (1998). Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58:204-209.
44. Teixeira MR, Pandis N, Bardi G, Andersen JA, and Heim S (1996). Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 56:855-859.
45. Teixeira MR, Pandis N, Bardi G, Andersen JA, Bohler PJ, Qvist H, and Heim S (1997). Discrimination between multi-centric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 18:170-174.
46. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mandahl N, Mitelman F, and Heim S (1994). Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer 70:922-927.
47. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F, and Heim S (1995). Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer 63:63-68.
48. Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, and Toda T (1999). Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Breast Cancer Res Treat 53:33-39.
49. Toyama T, Iwase H, Yamashita H, Iwata H, Yamashita T, Ito K, Hara Y, Suchi M, Kato T, Nakamura T, and Kobayashi S (1996). Microsatellite instability in sporadic human breast cancers. Int J Cancer 68:447-451.
50. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, and Bos JL (1988). Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532.
51. Walsh T, Chappell SA, Shaw JA, and Walker RA (1998). Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol 185:18-24.
52. Wolman SR (1986). Cytogenetic heterogeneity: its role in tumor evolution. Cancer Genet Cytogenet 19:129-140.
53. Wolman SR and Heppner GH (1992). Genetic heterogeneity in breast cancer [Editorial]. J Natl Cancer Inst 84:469-470.
54. Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD, Carnelisse CJ, Devilre P, and Stratton MR (1994). Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6:152-156.
55. Yee CJ, Roodi N, Verrier CS, and Parl FF (1994). Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54:1641-1644.